Columvi

Roche's Columvi win in earlier DLBCL faces questions over inconsistent patient survival data
Fierce Pharma
Sun, 06/16/24 - 08:57 pm
Roche
Columvi
diffuse large B-cell lymphoma
clinical trials
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Clinical Trials Arena
Mon, 04/15/24 - 11:07 am
Roche
clinical trials
Columvi
DLBCL
ASH: Roche offers glimpse of Columvi-Polivy combo's early lymphoma data as phase 3 kicks off
Fierce Pharma
Mon, 12/11/23 - 10:50 pm
Roche
ASH 2023
Columvi
Polivy
diffuse large B-cell lymphoma
Roche follows AbbVie with FDA approval for dual-targeting lymphoma drug
BioPharma Dive
Fri, 06/16/23 - 09:57 am
Roche
Columvi
FDA
relapsed or refractory diffuse large B-cell lymphoma
blood cancer